Arvinas (ARVN) EPS (Basic) (2017 - 2026)

Arvinas' (ARVN) quarterly EPS (Basic) came in at -$0.9 in Q1 2026, down 178.71% year-on-year from $1.14 in Q1 2025, and up 5.33% quarter-over-quarter from -$0.95 in Q4 2025.

Arvinas (ARVN) EPS (Basic) (2017 - 2026) Analysis & Trends

Arvinas' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.9 for Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 178.71% year-over-year to -$0.9 in Q1 2026; TTM through Mar 2026 was -$3.46, a 437.96% decrease from a year earlier, with the FY2025 full-year figure at -$1.14, up 58.8% from the prior year.
  • EPS (Basic) rose to -$0.9 in Q1 2026 per ARVN's latest filing, from -$0.95 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.14 in Q1 2025 and bottomed at -$2.79 in Q4 2023.
  • The 5-year median for EPS (Basic) is -$0.97 (2024), against an average of -$0.98.
  • Across the five-year window, EPS (Basic) soared 218.13% in 2025 and slumped 178.71% in 2026, its largest moves.
  • Year by year, EPS (Basic) stood at -$1.51 in 2022, then slumped by 85.25% to -$2.79 in 2023, then jumped by 77.51% to -$0.63 in 2024, then plunged by 51.55% to -$0.95 in 2025, then rose by 5.33% to -$0.9 in 2026.
  • Per Business Quant, the three latest ARVN EPS (Basic) figures stand at -$0.9 (Q1 2026), -$0.95 (Q4 2025), and -$0.48 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Arvinas 512.64 Mn -102.26 Mn - -0.90

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.90
Dec 31, 2025 -0.95
Sep 30, 2025 -0.48
Jun 30, 2025 -0.84
Mar 31, 2025 1.14
Dec 31, 2024 -0.63
Sep 30, 2024 -0.68
Jun 30, 2024 -0.49
Mar 31, 2024 -0.97
Dec 31, 2023 -2.79
Sep 30, 2023 -1.18
Jun 30, 2023 -1.22
Mar 31, 2023 -1.52
Dec 31, 2022 -1.51
Sep 30, 2022 -1.19
Jun 30, 2022 -1.27
Mar 31, 2022 -1.15
Dec 31, 2021 -0.92
Sep 30, 2021 -0.94
Jun 30, 2021 -1.03